Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAVGR.L Regulatory News (AVGR)

  • There is currently no data for AVGR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Solicitation Agent

23 Sep 2015 07:00

RNS Number : 8829Z
AvangardCo Investments Public Ltd
23 September 2015
 

NOT FOR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS OR TO ANY U.S. PERSON (AS DEFINED IN REGULATION S UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED).

 

23 September 2015

 

Appointment of UBS Limited as Solicitation Agent for Avangardco Investments Public Limited's UK Scheme of Arrangement

 

Appointment of Solicitation Agent

 

UBS Limited has been appointed as sole solicitation agent in relation to the UK scheme of arrangement (the "Scheme") launched on 17 September 2015 by Avangardco Investments Public Limited (the "Company") to seek the sanction of the High Court of Justice in England and Wales to (i) waive certain events of default (the "Waiver") under, and (ii) amend and extend (the "Amendments") the Company's US$200 million 10.0% Notes due 2015 (ISIN: XS0553088708) (the "Notes").

 

Requests for all information in relation to the above, including requests by holders of Notes for copies of the documentation, should be directed to:

 

UBS Limited

1 Finsbury Avenue

London EC2M 2PP

United Kingdom

 

Tel: +1-203-719-8682 / +44 20756 84601

E-mail: mark-t.watkins@ubs.com / torstein.berteig@ubs.com

Attention: Liability Management Group

 

 

Cash flows of amended Notes

 

The terms and conditions of the Scheme, including the Waiver and the Amendments, were announced by the Company on 17 September 2015 (the "Announcement") and are included in a Practice Statement Letter dated 17 September 2015 prepared in connection with the Scheme. You may access the Announcement, the Practice Statement Letter and other information in relation to the Scheme made available from time to time on the following website upon providing appropriate certifications: http://sites.dfkingltd.com/avangard.

 

A table of cash flows on the Notes following the implementation of the Scheme and the incorporation of the Amendments is set forth below.

Interest payment date

Principal amount outstanding[1][2]

Cash Interest %

PIK Interest %

Cash coupon[3]

PIK coupon[4]

Principal redemption

29/10/15

US$103,000

 40

 60

US$2,000

US$3,000

-

29/04/16

US$106,863

 25

 75

US$1,288

US$3,863

-

29/10/16

US$110,870

 25

 75

US$1,336

US$4,007

-

29/04/17

US$113,642

 50

 50

US$2,772

US$2,772

-

29/10/17

US$116,483

 50

 50

US$2,841

US$2,841

-

29/04/18

US$117,939

 75

 25

US$4,368

US$1,456

-

29/10/18

US$117,939

 100

 0

US$5,897

-

US$117,939

 

--------

 

Certain information about the Company, the Scheme, the Waiver, the Amendments and the Group's current acute shortage of liquidity has been included in a Practice Statement Letter dated 17 September 2015 prepared in connection with the Scheme. You may access the Practice Statement Letter and other information in relation to the Scheme made available from time to time on the following website upon providing appropriate certifications: http://sites.dfkingltd.com/avangard. For further information please contact D.F. King Ltd.

  

D.F. King Ltd. as the Scheme Information AgentEmail: avangard@dfkingltd.com

Website: sites.dfkingltd.com/avangard

 

In London:85 Gresham StreetLondon, EC2V 7NQUnited KingdomTelephone: +44 20 7920 9700

 

In Hong Kong:Suite 1601, 16/F, Central Tower28 Queen's Road CentralHong KongTelephone: +852 3953 7230

 

In New York:

48 Wall Street, 22nd Floor

New York, New York 10005

United States

Telephone: +1 212 269 5550

 

--------

 

This notice is neither an offer to purchase nor a solicitation of an offer to sell securities. The Scheme is not being made to any person in any jurisdiction in which the making of the Scheme would not be in compliance with the securities or other laws of such jurisdiction. The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold in the United States, unless registered under the Securities Act or unless an exemption from the registration requirements set forth in the Securities Act applies to them. No public offering of the securities will be made in the United States and the Company does not intend to make any such registration under the Securities Act.

 

In the United Kingdom, this communication is being distributed only to and is directed only at (a) persons who have professional experience in matters relating to investments falling within the definition of "investment professionals" in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order"), (b) high net worth entities falling within Article 49(2)(a) to (d) of the Order and (c) other persons to whom it may be lawfully communicated (all such persons together being referred to as "relevant persons"). Any person who is not a relevant person should not act or rely on this communication or any of its contents.

 

Statements contained herein may constitute "forward-looking statements". Forward-looking statements are generally identifiable by the use of the words "may", "will", "should", "aim", "plan", "expect", "anticipate", "estimate", "believe", "intend", "project", "goal" or "target" or the negative of these words or other variations on these words or comparable terminology.

 

Forward-looking statements involve a number of known and unknown risks, uncertainties and other factors that could cause the Company's or its industry's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. The Company does not undertake publicly to update or revise any forward-looking statement that may be made herein, whether as a result of new information, future events or otherwise.

 

 

 

 

 


[1] Principal amount outstanding immediately following the relevant interest payment.

[2] Calculation based on a holding of US$100,000 of Notes.

[3] Cash interest rounded to the nearest US dollar.

[4] PIK interest rounded to the nearest US dollar.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCZMGZLLZLGKZM
Date   Source Headline
3rd Nov 201111:12 amRNSNotice of EGM
18th Oct 20117:00 amRNSTrading Update
14th Oct 20113:11 pmRNSClarification re VAB Bank
14th Sep 201110:12 amRNSre: Share Ownership Transfer
13th Sep 20113:45 pmRNSSecond Price Monitoring Extn
13th Sep 20113:40 pmRNSPrice Monitoring Extension
30th Aug 20117:01 amRNSAGM Results
30th Aug 20117:00 amRNSHalf Yearly Report
22nd Aug 20113:45 pmRNSSecond Price Monitoring Extn
22nd Aug 20113:40 pmRNSPrice Monitoring Extension
8th Aug 20115:03 pmRNSNotice of AGM
8th Aug 20113:46 pmRNSSecond Price Monitoring Extn
8th Aug 20113:40 pmRNSPrice Monitoring Extension
29th Jul 20117:00 amRNSTrading Update
8th Jul 20114:41 pmRNSAvis Update
15th Jun 201112:09 pmRNSLLC Imperovo Foods receives AMCU permission
17th May 20113:45 pmRNSSecond Price Monitoring Extn
17th May 20113:40 pmRNSPrice Monitoring Extension
11th May 20116:12 pmRNSPublication of Prospectus
28th Apr 20115:35 pmRNSPublication of Annual Report & Accounts
26th Apr 20117:00 amRNSTrading Update
10th Mar 20113:45 pmRNSSecond Price Monitoring Extn
10th Mar 20113:40 pmRNSPrice Monitoring Extension
9th Mar 20117:00 amRNSBoard Appointment
4th Mar 20117:00 amRNSFinal Results
3rd Mar 20116:11 pmRNSChange of Results Date
2nd Mar 20117:00 amRNSNotice of Results
22nd Feb 20112:00 pmRNSre: Speculation
9th Feb 201112:40 pmRNSTrading Update
13th Jan 201112:42 pmRNSDebt Repayment
18th Nov 20108:24 amRNSClarification following recent press reports
2nd Nov 20107:00 amRNSCompletion of Bonds Issue
29th Oct 20107:00 amRNSTrading Statement
27th Oct 201012:47 pmRNSPublication of Prospectus
8th Oct 20106:00 pmRNSReg S Issue
6th Oct 20103:45 pmRNSSecond Price Monitoring Extn
6th Oct 20103:40 pmRNSPrice Monitoring Extension
29th Sep 20107:00 amRNSADR Notice
25th Aug 20107:00 amRNSHalf Year Results Statement
3rd Aug 20107:00 amRNSPre-Close Trading Update
22nd Jul 20101:06 pmRNSAnalyst Site Visit
29th Jun 20103:40 pmRNSPrice Monitoring Extension
28th Jun 20103:40 pmRNSPrice Monitoring Extension
22nd Jun 20103:15 pmRNSStatement re: VTB Bank
11th Jun 20103:40 pmRNSPrice Monitoring Extension
9th Jun 20103:40 pmRNSPrice Monitoring Extension
3rd Jun 20101:13 pmRNSPost Stabilisation Notice
28th May 20103:47 pmRNSExercise of over-allotment option
28th May 20103:45 pmRNSSecond Price Monitoring Extn
28th May 20103:40 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.